Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Endothelial dysfunction and cardiovascular disease in early-stage chronic kidney disease: cause or association?

Moody WE, Edwards NC, Madhani M, Chue CD, Steeds RP, Ferro CJ, Townend JN.

Atherosclerosis. 2012 Jul;223(1):86-94. doi: 10.1016/j.atherosclerosis.2012.01.043. Epub 2012 Feb 2. Review.

PMID:
22349087
2.

Understanding the effects of chronic kidney disease on cardiovascular risk: are there lessons to be learnt from healthy kidney donors?

Moody WE, Chue CD, Inston NG, Edwards NC, Steeds RP, Ferro CJ, Townend JN.

J Hum Hypertens. 2012 Mar;26(3):141-8. doi: 10.1038/jhh.2011.46. Epub 2011 May 19. Review.

PMID:
21593781
3.

Risk of cardiovascular disease in kidney donors as a chronic kidney disease cohort.

Naganuma T, Takemoto Y, Taiyou O, Hirokazu T, Masaki M, Maeda S, Nakatani T.

Mol Med Rep. 2012 Jan;5(1):7-11. doi: 10.3892/mmr.2011.629. Epub 2011 Oct 12.

PMID:
21993905
4.
5.

Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.

Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G.

Nephrol Dial Transplant. 2009 May;24(5):1528-33. doi: 10.1093/ndt/gfn692. Epub 2008 Dec 10.

PMID:
19073656
6.

Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease.

Lorenzen J, Krämer R, Kliem V, Bode-Boeger SM, Veldink H, Haller H, Fliser D, Kielstein JT.

Eur J Clin Invest. 2010 Apr;40(4):294-300. doi: 10.1111/j.1365-2362.2010.02271.x.

PMID:
20486990
7.

Is chronic kidney disease a cardiovascular disease risk factor?

Culleton BF, Hemmelgarn BR.

Semin Dial. 2003 Mar-Apr;16(2):95-100. Review.

PMID:
12641871
8.

Should eGFR and albuminuria be added to the Framingham risk score? Chronic kidney disease and cardiovascular disease risk prediction.

Chang A, Kramer H.

Nephron Clin Pract. 2011;119(2):c171-7; discussion c177-8. doi: 10.1159/000325669. Epub 2011 Jul 28. Review.

9.

Relationship between kidney disease and endothelial function in peripheral artery disease.

Chong KC, Owens CD, Park M, Alley HF, Boscardin WJ, Conte MS, Gasper WJ, Grenon SM.

J Vasc Surg. 2014 Dec;60(6):1605-11. doi: 10.1016/j.jvs.2014.08.105. Epub 2014 Oct 16.

10.

Rate of kidney function decline associates with mortality.

Al-Aly Z, Zeringue A, Fu J, Rauchman MI, McDonald JR, El-Achkar TM, Balasubramanian S, Nurutdinova D, Xian H, Stroupe K, Abbott KC, Eisen S.

J Am Soc Nephrol. 2010 Nov;21(11):1961-9. doi: 10.1681/ASN.2009121210. Epub 2010 Oct 14.

11.

Screening for CKD with eGFR: doubts and dangers.

Glassock RJ, Winearls C.

Clin J Am Soc Nephrol. 2008 Sep;3(5):1563-8. doi: 10.2215/CJN.00960208. Epub 2008 Jul 30.

12.

The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study: objectives, design, and methodology.

Querfeld U, Anarat A, Bayazit AK, Bakkaloglu AS, Bilginer Y, Caliskan S, Civilibal M, Doyon A, Duzova A, Kracht D, Litwin M, Melk A, Mir S, Sözeri B, Shroff R, Zeller R, Wühl E, Schaefer F; 4C Study Group..

Clin J Am Soc Nephrol. 2010 Sep;5(9):1642-8. doi: 10.2215/CJN.08791209. Epub 2010 Jun 24.

13.

Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes.

Yilmaz MI, Sonmez A, Ortiz A, Saglam M, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Çakar M, Egido J, Altun B, Yenicesu M, Blanco-Colio LM, Carrero JJ.

Clin J Am Soc Nephrol. 2011 Apr;6(4):785-92. doi: 10.2215/CJN.09231010. Epub 2011 Feb 17.

14.
15.

The relationship between IL-10 levels and cardiovascular events in patients with CKD.

Yilmaz MI, Solak Y, Saglam M, Cayci T, Acikel C, Unal HU, Eyileten T, Oguz Y, Sari S, Carrero JJ, Stenvinkel P, Covic A, Kanbay M.

Clin J Am Soc Nephrol. 2014 Jul;9(7):1207-16. doi: 10.2215/CJN.08660813. Epub 2014 May 1.

16.

The combination of chronic kidney disease and increased arterial stiffness is a predictor for stroke and cardiovascular disease in hypertensive patients.

Ohishi M, Tatara Y, Ito N, Takeya Y, Onishi M, Maekawa Y, Kato N, Kamide K, Rakugi H.

Hypertens Res. 2011 Nov;34(11):1209-15. doi: 10.1038/hr.2011.117. Epub 2011 Aug 4.

PMID:
21814210
17.

Significance of past history of renal failure for the detection of high-risk individuals for cardiovascular and end-stage renal disease: analysis of data from a nationwide health checkup.

Ichikawa K, Konta T, Ikeda A, Fujimoto S, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Yoshida H, Asahi K, Kurahashi I, Ohashi Y, Watanabe T.

Clin Exp Nephrol. 2011 Dec;15(6):841-7. doi: 10.1007/s10157-011-0509-y. Epub 2011 Aug 5.

PMID:
21818546
18.

[Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].

Grabysa R, Cholewa M.

Pol Merkur Lekarski. 2008 Jun;24(144):487-91. Polish.

PMID:
18702327
19.

Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.

Chitalia N, Raja RB, Bhandara T, Agrawal P, Kaski JC, Jha V, Banerjee D.

J Nephrol. 2010 Jan-Feb;23(1):77-84.

PMID:
20091490
20.

Cardiovascular disease and its relationship with chronic kidney disease.

Liu M, Li XC, Lu L, Cao Y, Sun RR, Chen S, Zhang PY.

Eur Rev Med Pharmacol Sci. 2014 Oct;18(19):2918-26. Review.

Supplemental Content

Support Center